Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
Sales | 733 | 289 | 245 | 0 | 0 |
Gross Profit | 733 | 289 | 245 | N/A | N/A |
Operating Expenses | 12,083 | 9,135 | 7,902 | 7,298 | 6,687 |
Operating Income | -11,350 | -8,846 | -7,657 | -7,298 | -6,687 |
Interest Expense | 0 | 0 | 0 | 144 | 286 |
Other Income | 24 | -49 | -3 | -3 | -14 |
Pre-tax Income | -11,326 | -8,895 | -7,660 | -7,445 | -6,987 |
Net Income Continuous | -11,326 | -8,895 | -7,660 | -7,445 | -6,987 |
Net Income | $-11,326 | $-8,895 | $-7,660 | $-7,445 | $-6,987 |
EPS Basic Total Ops | -2.32 | -2.00 | -2.24 | -2.56 | -2.48 |
EPS Basic Continuous Ops | -2.31 | -1.99 | -2.22 | -2.57 | -2.46 |
EPS Diluted Total Ops | -2.32 | -2.00 | -2.24 | -2.56 | -2.48 |
EPS Diluted Continuous Ops | -2.31 | -1.99 | -2.22 | -2.57 | -2.46 |
EBITDA(a) | $-11,277 | $-8,774 | $-7,589 | $-6,941 | $-6,515 |